Hip Replacement Recall Involves Lanier, Johnson & Johnson

LOS ANGELES – The Lanier Law Firm is providing information for patients following the announcement that Johnson & Johnson (NYSE: JNJ) is recalling two hip replacement implants based on the high number of people requiring a second surgery. Attorneys from the firm have more than a decade of experience in hip implant replacement cases.

The recalled implants were manufactured by Johnson & Johnson’s DePuy/J&J Orthopaedics Inc. unit, and include the ASR XL Acetabular System and DePuy/J&J ASR Hip Resurfacing System. More than 93,000 patients purchased the two implants before the company stopped production last year. Johnson & Johnson recorded worldwide sales of nearly $62 billion in 2009, with its DePuy/J&J unit accounting for more than $5 billion.

The Lanier Law Firm is one of the country’s top trial law firms. In 2001, attorneys from the firm helped hundreds of people who faced a second, “explant” surgery to remove defective Inter-Op brand hip replacement implants sold by Sulzer Orthopedics. The Sulzer recall resulted in a nationwide settlement of $1.2 billion for patients.

A recent study revealed that more than 10 percent of patients with the ASR XL Acetabular System  and DePuy/J&J ASR Hip Resurfacing System have required corrective surgery within five years of their original procedures. The recalled implants include metal-on-metal contact, which has been criticized by surgeons because of the likelihood of metal shavings causing problems in surrounding tissue.

Acclaimed trial lawyer and firm founder Mark Lanier says: “Johnson & Johnson is a huge company that should know better but they’ve kept pushing this dangerous product despite the obvious problems.”